Clinical trial · Interventional
Use of Integrated Pulmonary Index Monitorisation in Children Undergoing Botulinum Toxin Injection
Effect of Integrated Pulmonary Index on Hypoxia
NCT05724030CI-TRIAL-00081609completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aimed to detect hypoxia early with ıntegrated pulmonary index monitoring compared to saturation.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cerebral Palsy | — | UNRESOLVED | — |
| Pediatric ALL | Childhood Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| integrated pulmonary index | Device | — | UNRESOLVED |
| saturation | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- integrated pulmonary index hypoxia -capnogarph
- description
- integrated pulmonary index montorization apliied
- interventionNames
- Device: integrated pulmonary index
- Device: saturation
- type
- EXPERIMENTAL
- label
- saturation - apnea
- description
- saturation apllied
- interventionNames
- Device: integrated pulmonary index
- Device: saturation
Primary outcomes (1)
- measure
- hypoxia
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 4 Years
- Maximum age
- 16 Years
Show eligibility criteria text
Inclusion Criteria: * 4-16 age pediatrics * undergoing botilinum injection with sedation * asa 1-2 Exclusion Criteria: * \> 18 age * asa 3-4 * patients with upper respiratory tract infection
References
Publications (0)
Data not yet available
No reference posted for this study.